Charles Schwab Investment Management Inc. Sells 102,095 Shares of ProAssurance Co. (NYSE:PRA)

Charles Schwab Investment Management Inc. lowered its stake in ProAssurance Co. (NYSE:PRA - Free Report) by 12.5% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 712,617 shares of the insurance provider's stock after selling 102,095 shares during the quarter. Charles Schwab Investment Management Inc. owned about 1.39% of ProAssurance worth $10,718,000 at the end of the most recent reporting period.

Other large investors also recently made changes to their positions in the company. Assenagon Asset Management S.A. lifted its position in ProAssurance by 91.4% during the 3rd quarter. Assenagon Asset Management S.A. now owns 485,501 shares of the insurance provider's stock worth $7,302,000 after buying an additional 231,852 shares in the last quarter. Cubist Systematic Strategies LLC grew its holdings in shares of ProAssurance by 567.5% in the 2nd quarter. Cubist Systematic Strategies LLC now owns 151,434 shares of the insurance provider's stock valued at $1,851,000 after acquiring an additional 128,747 shares in the last quarter. Dana Investment Advisors Inc. increased its position in shares of ProAssurance by 33.6% in the second quarter. Dana Investment Advisors Inc. now owns 434,850 shares of the insurance provider's stock valued at $5,314,000 after acquiring an additional 109,253 shares during the last quarter. Smith Thornton Advisors LLC bought a new stake in ProAssurance during the second quarter worth about $821,000. Finally, Connor Clark & Lunn Investment Management Ltd. boosted its position in ProAssurance by 402.1% during the third quarter. Connor Clark & Lunn Investment Management Ltd. now owns 68,435 shares of the insurance provider's stock valued at $1,029,000 after purchasing an additional 54,806 shares during the last quarter. Institutional investors own 85.58% of the company's stock.

Analysts Set New Price Targets

A number of equities research analysts have recently issued reports on the company. Truist Financial upped their price objective on ProAssurance from $14.00 to $18.00 and gave the stock a "hold" rating in a research note on Tuesday, November 12th. Piper Sandler downgraded shares of ProAssurance from an "overweight" rating to a "neutral" rating and set a $18.00 target price on the stock. in a report on Monday, November 11th. Finally, StockNews.com cut shares of ProAssurance from a "buy" rating to a "hold" rating in a research note on Tuesday, November 19th.

ProAssurance Stock Performance

Shares of PRA traded down $0.06 during mid-day trading on Tuesday, reaching $16.78. The company's stock had a trading volume of 98,852 shares, compared to its average volume of 280,514. The company has a current ratio of 0.28, a quick ratio of 0.28 and a debt-to-equity ratio of 0.35. ProAssurance Co. has a 1-year low of $10.76 and a 1-year high of $17.79. The business has a 50-day simple moving average of $15.85 and a two-hundred day simple moving average of $13.95. The stock has a market cap of $858.46 million, a P/E ratio of 20.29 and a beta of 0.27.

ProAssurance Company Profile

ProAssurance Corporation, through its subsidiaries, provides property and casualty insurance, and reinsurance products in the United States. The company operates through Specialty Property and Casualty, Workers' Compensation Insurance, and Segregated Portfolio Cell Reinsurance segments. It offers professional liability insurance to healthcare providers and institutions, and attorneys and their firms; medical technology liability insurance to medical technology and life sciences companies; and custom alternative risk solutions, including assumed reinsurance, loss portfolio transfers, and captive cell programs for healthcare professional liability insureds.